The Cervix Translational Working Group (Cervix TWG) includes 12 members from the following research programs: Cancer Prevention and Control, Carcinogenesis and Growth Factors and Signaling. The Cervix TWG is a component of the Cancer Prevention and Control Research Program

Current Focus

• Population Sciences
• Molecular Genetics
• Immunology
• Biostatistics

Group Co-Leaders

Lari Wenzel, Ph.D.
Krishnansu Tewari, M.D.

Program Leaders

Hoda Anton-Culver, Ph.D.
Frank Meyskens, M.D.

Summary of Ongoing Clinical Trials and Research Projects

Cervix TWG members are the key personnel involved in five clinical trials underway at Chao Family Comprehensive Cancer Center and across the nation and five distinct projects that focus on cervical cancer translational research. They are also involved in innovative new projects in cervical cancer that are being developed as applications for NCI grant funding.